
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bee venom therapy uses apitoxin, a complex mixture containing melittin as the primary bioactive peptide, to treat inflammatory conditions through immune modulation. Melittin disrupts inflammatory pathways by inhibiting phospholipase A2 and reducing pro-inflammatory cytokine production.

Reported Benefits (Provisional)
Origin & History

Bee Venom Therapy, also known as Apitoxin, involves the use of bee venom for therapeutic purposes. It is extracted from honeybees and contains a complex mixture of proteins and peptides. This therapy is often administered through bee stings or injections.
Research Narrative (Provisional)
RCTs and observational studies suggest benefits for arthritis and pain management. Some studies highlight its immune-modulating effects, though more research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains melittin, a potent anti-inflammatory peptide. - Includes apamin, which may support nerve function. - Rich in enzymes and amino acids.
Reported Mechanism (Provisional)
Melittin, the primary active peptide in bee venom, inhibits phospholipase A2 enzyme activity, reducing inflammatory mediator production. It modulates immune responses by suppressing NF-κB signaling pathways and decreasing TNF-α, IL-1β, and IL-6 cytokine levels. The therapy also stimulates cortisol release and activates anti-inflammatory pathways through the hypothalamic-pituitary-adrenal axis.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving 30-100 participants have demonstrated bee venom therapy's effectiveness for rheumatoid arthritis and osteoarthritis pain reduction. A 2018 systematic review of 145 studies showed significant pain reduction (30-50% decrease in VAS scores) in arthritis patients. However, most studies are small-scale with short follow-up periods, and larger long-term trials are needed to establish optimal protocols. Evidence is strongest for musculoskeletal conditions but limited for other therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







